What sector does Genovate Biotechnology Co Ltd (4130) operate in?
Genovate Biotechnology Co Ltd belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Genovate Biotechnology Co Ltd (4130) current stock price?
As of the latest data, Genovate Biotechnology Co Ltd stock price is NT$20.95, with a previous close of NT$21.00. Genovate Biotechnology Co Ltd lost -NT$0.05 in the last trading session, representing a -0.24% loss.
What is Genovate Biotechnology Co Ltd (4130) current market capitalization?
Genovate Biotechnology Co Ltd market cap is approximately 2.34 billion.
What is Genovate Biotechnology Co Ltd (4130) Earnings Per Share (EPS)?
The trailing EPS is NT$0.14.
What is Genovate Biotechnology Co Ltd (4130) Price-to-Earnings (P/E) ratio?
Genovate Biotechnology Co Ltd current P/E ratio is 149.64.
Does Genovate Biotechnology Co Ltd (4130) dividends?
Yes. Genovate Biotechnology Co Ltd pays annual dividends with a forward yield of 0.72% and a forward payout of NT$0.15 per share.
When is the next ex-dividend date for Genovate Biotechnology Co Ltd (4130)?
The next ex-dividend date is scheduled for August 21, 2025.
When is Genovate Biotechnology Co Ltd (4130) next earnings report?
Genovate Biotechnology Co Ltd is expected to release its next earnings report on March 31, 2025.